Many good reasons to have STAT3 in the heart
- 1 July 2005
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 107 (1) , 131-137
- https://doi.org/10.1016/j.pharmthera.2005.02.003
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo MalignancyCancer Research, 2004
- Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioningCardiovascular Research, 2004
- Principles of interleukin (IL)-6-type cytokine signalling and its regulationBiochemical Journal, 2003
- What does Stat3 do?Journal of Clinical Investigation, 2002
- Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF‐induced angiogenesisThe FASEB Journal, 2001
- A Novel Role for STAT3 in Cardiac RemodelingTrends in Cardiovascular Medicine, 2000
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Postnatal Growth of the Heart and Its Blood VesselsJournal of Vascular Research, 1996